<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03632499</url>
  </required_header>
  <id_info>
    <org_study_id>63518</org_study_id>
    <nct_id>NCT03632499</nct_id>
  </id_info>
  <brief_title>An Algorithm for Prognosis of Upper Limb Paresis in Patients With Subacute Stroke</brief_title>
  <official_title>From Research to Clinical Practice. Applying an Algorithm for Prognosis of Upper Limb Paresis in Patients With Subacute Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim study 1:Assess the accuracy of PREP2 when applied in a subacute rehabilitation setting.&#xD;
&#xD;
      Aim study 2: Prediction of real life UL use. Method: A prospective cohort study. Main outcome&#xD;
      measure study 1: Action Research Arm Test (ARAT), measuring UL motor function.&#xD;
&#xD;
      Main outcome study 2: use ratio between affected and unaffected UL measured by&#xD;
      accellerometer.&#xD;
&#xD;
      Secondary outcome measure: Fugl-Meyer Motor Assessment for UL (FM).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background Accurate prediction of recovery of UL function after stroke can lead to targeted&#xD;
      rehabilitation. The Predict Recovery Potential (PREP2) algorithm combines individual&#xD;
      prediction of UL function with recommendations for treatment. The PREP2 algorithm is based on&#xD;
      clinical assessment of UL paresis combined with transcranial magnetic stimulation (TMS) to&#xD;
      examine corticospinal tract integrity. For this PhD project the PREP2 is modified to be&#xD;
      applicable in a rehabilitation setting and the initial assessment of PREP2, the SAFE score,&#xD;
      is carried out at day 14.&#xD;
&#xD;
      Study 1 Aim: Assess the accuracy of PREP2 when applied in a subacute rehabilitation setting.&#xD;
&#xD;
      Hypothesis: PREP2 applied at day 14 post stroke accurately predicts UL function 3 months&#xD;
      after stroke for a minimum of 75 % of the patients.&#xD;
&#xD;
      Method: A prospective cohort study. Setting and population: The study will take place at&#xD;
      Hammel Neurorehabilitation Centre and University Research Clinic. Ninety patients will be&#xD;
      included.&#xD;
&#xD;
      Inclusion criteria: First or recurrent ischemic or hemorrhagic stroke (diagnosis verified by&#xD;
      CT or MR scan); New upper limp impairment; Less than 15 days post stroke; ≥ 18 years; Able to&#xD;
      follow simple commands and cooperate with examinations Main outcome measure: Action Research&#xD;
      Arm Test (ARAT), measuring UL motor function.&#xD;
&#xD;
      Secondary outcome measure: Fugl-Meyer Motor and sensory Assessment for UL. Functional&#xD;
      Independence Measure (FIM).&#xD;
&#xD;
      Examined at baseline: Pain wil be assessed with a verbal rating scale. Inferior subluxation&#xD;
      in the glenohumoral joint. Neglect will be assessed with star cancellation test and line&#xD;
      bisection test&#xD;
&#xD;
      Study 2 Prediction of real life UL use Hypothesis: PREP2 can be used to predict real life UL&#xD;
      use 3 months post stroke. Patients: The entire cohort from study 1 will be included. Real&#xD;
      life use will be assessed with accelerometers at 3 months follow up.&#xD;
&#xD;
      Main outcome: is the use ratio between affected and unaffected UL.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 15, 2018</start_date>
  <completion_date type="Actual">March 15, 2020</completion_date>
  <primary_completion_date type="Actual">October 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Action Research Arm test</measure>
    <time_frame>dec 2019</time_frame>
    <description>Upper limb function test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fugl Meyer Motor and sensory assesment</measure>
    <time_frame>Dec 2019</time_frame>
    <description>Upper limb function test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accellerometry</measure>
    <time_frame>dec 2019</time_frame>
    <description>accellerometer</description>
  </secondary_outcome>
  <enrollment type="Actual">103</enrollment>
  <condition>Stroke</condition>
  <condition>Upper Limb Hypertonia</condition>
  <condition>Physical Activity</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>rehabilitation</intervention_name>
    <description>rehabilitation</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with stroke in a rehabilitation setting&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  First or recurrent ischemic or hemorrhagic stroke (diagnosis verified by CT or MR&#xD;
             scan)&#xD;
&#xD;
          -  New upper limp impairment; Less than 15 days post stroke&#xD;
&#xD;
          -  ≥ 18 years&#xD;
&#xD;
          -  Able to follow simple commands and cooperate with examinations&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subarachnoid hemorrhages&#xD;
&#xD;
          -  UL motor residuals from former stroke&#xD;
&#xD;
          -  Severe illness with life expectancy &lt; 6 months&#xD;
&#xD;
          -  Place of residence more than 1½ hours drive away and not reachable for follow up&#xD;
             assessments&#xD;
&#xD;
          -  Patients with contraindications for TMS are excluded from the TMS part of the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Iris Brunner, phd</last_name>
    <role>Study Chair</role>
    <affiliation>Iris.Brunner@rm.dk</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Camilla Lundquist</name>
      <address>
        <city>Hammel</city>
        <zip>8470</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <study_first_submitted>August 13, 2018</study_first_submitted>
  <study_first_submitted_qc>August 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2018</study_first_posted>
  <last_update_submitted>March 3, 2021</last_update_submitted>
  <last_update_submitted_qc>March 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Paresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

